Bank of Nova Scotia Trust’s Elevance Health ELV Stock Holding History

Bank of Nova Scotia Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$232K	Sell	793 -184	-19%	-$60.5K	0.02%	150
2025 Q4	$342K	Buy	977 +199	+26%	+$67.2K	0.03%	125
2025 Q3	$251K	Buy	+778	New	+$242K	0.02%	118
2017 Q4	–	Sell	-10	Closed	-$2K	–	204
2017 Q3	$2K	Sell	10 -3,690	-100%	-$702K	﹤0.01%	422
2017 Q2	$696K	Sell	3,700 -8,250	-69%	-$1.48M	0.08%	79
2017 Q1	$1.98M	Sell	11,950 -7,065	-37%	-$1.12M	0.22%	56
2016 Q4	$2.73M	Buy	19,015 +8,775	+86%	+$1.17M	0.31%	50
2016 Q3	$1.28M	Buy	+10,240	New	+$1.32M	0.15%	62

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Bank of Nova Scotia Trust's ELV Position: Q1 2026 in Review

Bank of Nova Scotia Trust reduced its Elevance Health (ELV) stake by 19% in Q1 2026, selling an estimated $60.5K and leaving 793 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #150.

Bank of Nova Scotia Trust first reported a position in ELV in Q3 2016 and has held it in 8 quarters since. The position peaked at $2.73M in Q4 2016. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Bank of Nova Scotia Trust held 793 shares of Elevance Health worth $232K as of Q1 2026.
Bank of Nova Scotia Trust sold 184 Elevance Health shares in Q1 2026, an estimated $60.5K.
Elevance Health made up 0.02% of Bank of Nova Scotia Trust's portfolio in Q1 2026, its #150 holding.
Bank of Nova Scotia Trust first reported a position in Elevance Health in Q3 2016 and has held it in 8 quarters since.
Bank of Nova Scotia Trust's Elevance Health position peaked at $2.73M in Q4 2016.
1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Bank of Nova Scotia Trust's 13F filing for Q1 2026, filed 13 May 2026.